Article
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
Fecha
2019Registro en:
28, 1, 93-97
13543784
Autor
Camins A.
Ettcheto M.
Busquets O.
Manzine P.R.
Castro-Torres R.D.
Beas-Zarate C.
Verdaguer E.
Sureda F.X.
Bulló M.
Olloquequi J.
Auladell C.
Folch J.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts
Fabiani, Camila; Antollini, Silvia Susana (Frontiers Media S.A., 2019-07-18)Biological membranes show lateral and transverse asymmetric lipid distribution. Cholesterol (Chol) localizes in both hemilayers, but in the external one it is mostly condensed in lipid-ordered microdomains (raft domains), ... -
N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers
Decker, Helena; Jürgensen, Sofia; Adrover, Martín Federico; Brito Moreira, Jordano; Bomfim, Theresa R.; Klein, William L.; Epstein, Alberto L.; De Felice, Fernanda G.; Jerusalinsky, Diana Alicia; Ferreira, Sergio Teixeira -
Regulation of Na(+)/H(+) exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells
CARRARO-LACROIX, Luciene R.; MALNIC, Gerhard; GIRARDI, Adriana C. C. (AMER PHYSIOLOGICAL SOC, 2009)Carraro-Lacroix LR, Malnic G, Girardi AC. Regulation of Na(+)/H(+) exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal Physiol 297: F1647-F1655, 2009. ...